Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

CANTOS

ESC Congress 2017: CANTOS shows it’s not all about lipids

ESC Congress 2017: CANTOS shows it’s not all about lipids

The CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) study (1) showed that treatment with canakinumab, an inhibitor of interleukin-1β (IL-1β), reduced the risk of major adverse cardiovascular events. Lead author, Professor Paul Ridker (Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital, Boston, USA) compared…

read more »